Controlling Microbial Growth in the Body: Antimicrobial Drugs

Controlling Microbial Growth in the Body: Antimicrobial Drugs

Brief History of Antimicrobial Agents

The development of antimicrobial drugs revolutionized the treatment of infectious diseases. Key contributors include Paul Ehrlich (selective toxicity, Salvarsan for syphilis), Alexander Fleming (discovery of penicillin), Gerhard Domagk (sulfanilamide), and Selman Waksman/Albert Schatz (streptomycin from Streptomyces). Modern antibiotics include semisynthetic and synthetic derivatives.

• Selective toxicity: The ability of a drug to target pathogens without harming the host.

• Magic bullets: Ehrlich's concept of drugs that specifically target disease-causing organisms.

• Streptomycin: First effective antibiotic against tuberculosis.

Mechanisms of Antimicrobial Action

Antimicrobial drugs act by targeting specific structures or processes in microbes. The five main mechanisms are:

• Inhibition of cell wall synthesis: Prevents formation of peptidoglycan, leading to cell lysis. Beta-lactams (e.g., penicillin, amoxicillin) contain a β-lactam ring and block cross-linking of NAM subunits. Vancomycin blocks alanine-alanine linkage in Gram-positive bacteria (narrow-spectrum).

• Inhibition of protein synthesis: Targets prokaryotic ribosomes, disrupting translation. Examples include erythromycin and tetracycline.

• Disruption of cytoplasmic membranes: Some drugs (e.g., polymyxin B) form channels in membranes, causing leakage of cell contents.

• Inhibition of metabolic pathways: Antimetabolic agents (e.g., sulfonamides) block unique bacterial reactions, such as para-aminobenzoic acid synthesis needed for nucleotide production.

• Inhibition of nucleic acid synthesis: Drugs like quinolones (ciprofloxacin, nalidixic acid) inhibit DNA gyrase; rifampin inhibits RNA polymerase.

Example:

Penicillin inhibits cell wall synthesis; erythromycin inhibits protein synthesis; polymyxin B disrupts membranes; sulfamethoxazole/trimethoprim inhibit metabolic pathways; nalidixic acid inhibits nucleic acid synthesis.

Spectrum of Activity

The spectrum of activity refers to the range of pathogens a drug can affect. Narrow-spectrum antibiotics target specific groups, while broad-spectrum antibiotics affect a wide variety of organisms.

• Narrow-spectrum: Effective against a limited group (e.g., vancomycin for Gram-positives).

• Broad-spectrum: Effective against many types (e.g., tetracycline).

Clinical Considerations in Antimicrobial Therapy

When prescribing antimicrobials, clinicians consider spectrum of action, efficacy, and adverse effects.

• Efficacy: Determined by dosage, route of administration, and safety.

• Routes of administration: Topical, oral, intramuscular, intravenous. Each affects drug concentration and excretion differently.

• Adverse effects: Toxicity (kidneys, liver, nervous system), allergic reactions, disruption of normal microbiota (e.g., Clostridium difficile colitis).

• Therapeutic index: Ratio of tolerated dose to effective dose.

Efficacy Testing of Antimicrobial Agents

Laboratory tests assess the effectiveness of antibiotics:

• Diffusion susceptibility test (Kirby-Bauer): Measures zones of inhibition around antibiotic disks on agar plates.

• Minimum inhibitory concentration (MIC): Lowest concentration preventing visible growth.

• Minimum bactericidal concentration (MBC): Lowest concentration killing the organism.

Example:

Kirby-Bauer test results are interpreted using standard tables to determine susceptibility or resistance.

Antibiotic Resistance

Resistance can be natural or acquired through mutation or gene transfer (transformation, transduction, conjugation). Exposure to antibiotics selects for resistant strains.

• Mechanisms of resistance:

  • Enzyme production (e.g., β-lactamase destroys penicillin)

  • Reduced drug entry

  • Altered drug target

  • Efflux pumps

• Multi-drug resistance: Acquisition of R-plasmids can confer resistance to multiple drugs, leading to "superbugs".

Avoiding/Reducing Antibiotic Resistance

Strategies to prevent resistance include maintaining sufficient drug concentration, using drugs only for bacterial infections, and combining agents for multidrug-resistant organisms.

• Bacteriostatic vs. bactericidal: Bacteriostatic drugs inhibit growth; bactericidal drugs kill bacteria.

• Synergism: Combined drugs may have enhanced effects.

Example:

Synergism between two antimicrobial agents can be observed in laboratory tests, where the combined effect is greater than either drug alone.

Additional info: The image shows two agar plates with antibiotic disks. Plate A demonstrates synergism (larger zone of inhibition where two agents are combined), while Plate B shows no synergism (zones are not enhanced). This visualizes how synergistic combinations can improve antimicrobial efficacy.

Contributions to Microbiology

• Paul Ehrlich: Developed concept of selective toxicity and Salvarsan for syphilis.

• Alexander Fleming, Ernst Florey, Howard Chain: Discovered and developed penicillin.

• Gerhard Domagk: Developed sulfanilamide.

• Selman Waksman, Albert Schatz: Isolated streptomycin, effective against tuberculosis.